BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2195451)

  • 1. [In vitro sensitivity of Chlamydiae to antibiotics].
    Dailloux M; Ottemer C; Albert H; Weber M
    Pathol Biol (Paris); 1990 May; 38(5):426-30. PubMed ID: 2195451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
    Bianchi A; Legouge R; Lefevre JC; Askienazy-Elbhar M; Joly-Guillou ML; Pavis A; Sednaoui P
    Pathol Biol (Paris); 1996 May; 44(5):347-50. PubMed ID: 8758473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of a new quinolone, NM 394, against Chlamydia trachomatis].
    Poutiers F; de Barbeyrac B; Garcia-Mace J; Bebear C
    Pathol Biol (Paris); 1996 May; 44(5):351-4. PubMed ID: 8758474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry.
    Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B
    Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antichlamydial activity of ofloxacin.
    Hirai K; Une T
    Microbiol Immunol; 1986; 30(5):445-50. PubMed ID: 3462450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the inhibitory concentration 50% (IC50) of four selected drugs (chlortetracycline, doxycycline, enrofloxacin and difloxacin) that reduce in vitro the multiplication of Chlamydophila psittaci.
    Failing K; Theis P; Kaleta EF
    Dtsch Tierarztl Wochenschr; 2006 Nov; 113(11):412-7. PubMed ID: 17147151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro and in vivo activity of spiramycine on Chlamydia (author's transl)].
    Orfila J; Haider F; Thomas D
    Pathol Biol (Paris); 1982 Jun; 30(6):449-51. PubMed ID: 7050851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp.
    Donati M; Rodrìguez Fermepin M; Olmo A; D'Apote L; Cevenini R
    J Antimicrob Chemother; 1999 Jun; 43(6):825-7. PubMed ID: 10404322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A method for the determination of antibiotic sensitivity of chlamydias in vitro].
    Henning K; Krauss H
    Zentralbl Veterinarmed B; 1986 Aug; 33(6):447-61. PubMed ID: 3788356
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bacteriostatic and bactericidal activities of cyclines, macrolides and fluoroquinolones against Chlamydia trachomatis].
    Dailloux M; Villemain P
    Pathol Biol (Paris); 1992 May; 40(5):455-60. PubMed ID: 1495827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activity of garenoxacin against Chlamydia spp.
    Donati M; Pollini GM; Sparacino M; Fortugno MT; Laghi E; Cevenini R
    J Antimicrob Chemother; 2002 Sep; 50(3):407-10. PubMed ID: 12205067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
    Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
    Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of ultrasound and antibiotics against Chlamydia trachomatis-infected human epithelial cells in vitro.
    Ikeda-Dantsuji Y; Feril LB; Tachibana K; Ogawa K; Endo H; Harada Y; Suzuki R; Maruyama K
    Ultrason Sonochem; 2011 Jan; 18(1):425-30. PubMed ID: 20728399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
    Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology of Chlamydia.
    Bergan T
    Scand J Infect Dis Suppl; 1982; 32():11-5. PubMed ID: 6958006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time PCR for pharmacodynamic studies of Chlamydia trachomatis.
    Storm M; Gustafsson I; Herrmann B; Engstrand L
    J Microbiol Methods; 2005 Jun; 61(3):361-7. PubMed ID: 15767012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of antichlamydial effect of rokitamycin].
    Soejima R; Hino J; Nakagawa Y; Kishimoto T; Matsumoto A
    Jpn J Antibiot; 1988 Jul; 41(7):830-5. PubMed ID: 3172456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of a novel polyherbal formulation BASANT for prevention of Chlamydia trachomatis infection.
    Bhengraj AR; Dar SA; Talwar GP; Mittal A
    Int J Antimicrob Agents; 2008 Jul; 32(1):84-8. PubMed ID: 18524545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of in vitro activity of ofloxacin against 73 strains of Chlamydia trachomatis isolated from gynecologic infections].
    Catalan F; Milovanovic A; Prouteau C; Soulignac M
    Pathol Biol (Paris); 1998 Feb; 46(2):144-6. PubMed ID: 9769927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.
    Smelov V; Perekalina T; Gorelov A; Smelova N; Artemenko N; Norman L
    Eur Urol; 2004 Nov; 46(5):647-50. PubMed ID: 15474277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.